Home » Topics » BioWorld Science

BioWorld Science
RSS

CAMP4 raises funds to expand its platform and advance multiple RNA therapies

June 16, 2021

Avidea advances lead SNAPvax TV candidate for MS toward clinic

June 16, 2021

Veraxa partners with Quadira on ADCs for oncology indications

June 16, 2021

LLT1 is a poor prognostic factor in HPV-negative oropharyngeal SCC

June 16, 2021

LEO Pharma initiates phase IIa study of LEO-152020 in cholinergic urticaria

June 16, 2021

FDA clears IND application for phase II study of LPCN-1154 in postpartum depression

June 16, 2021

XWPharma reports phase I data on XW-10172 for sleep disorders

June 15, 2021

EyeGate begins phase II proof-of-concept study of PP-001 for ocular surface inflammation

June 15, 2021

Mindset reports first preclinical psychedelic benchmark data from COPE program

June 15, 2021

FDA clears IND for lisaftoclax for ER-positive breast cancer and other solid tumors

June 15, 2021

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...